Segall Bryant & Hamill’s Loxo Oncology, Inc LOXO Stock Holding History

Segall Bryant & Hamill’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4,493	Closed	-$629K	–	880
2018 Q4	$629K	Sell	4,493 -226	-5%	-$34.3K	0.01%	608
2018 Q3	$806K	Buy	+4,719	New	+$793K	0.01%	590

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Segall Bryant & Hamill's LOXO Position: Q1 2019 in Review

Segall Bryant & Hamill sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 4,493 shares — an estimated $629K sold.

Segall Bryant & Hamill first reported a position in LOXO in Q3 2018 and held it in 2 quarters. The position peaked at $806K in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Segall Bryant & Hamill reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Segall Bryant & Hamill sold 4,493 Loxo Oncology, Inc shares in Q1 2019, an estimated $629K.
Segall Bryant & Hamill first reported a position in Loxo Oncology, Inc in Q3 2018 and held it in 2 quarters.
Segall Bryant & Hamill's Loxo Oncology, Inc position peaked at $806K in Q3 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Segall Bryant & Hamill's 13F filing for Q1 2019, filed 15 May 2019.